Matthew Nojoomi
Principal investigator, leads Ictero Medical, Inc..
MedtechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$3.2MFederal grants as PI3 awards
1Patents grantedLatest Aug 27, 2024
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
3 awards · $3.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Dec 15, 2022 | NSF | SBIR Phase II SBIR Phase II:High Surface Area (HSA) Intraluminal Cryoablation for the Treatment of High-Risk Patients with Gallstone Disease | $1.5M | Ictero Medical, Inc. |
| Dec 9, 2022 | NSF | SBIR Phase II SBIR Phase II: High Surface Area (HSA) Intraluminal Cryoablation for the Treatment of High-Risk Patients with Gallstone Disease | $1.5M | Ictero Medical, Inc. |
| Dec 23, 2019 | NSF | SBIR Phase I SBIR Phase I: High Surface Area (HSA) Intraluminal Cryoablation for the Treatment of High-risk Patients with Gallstone Disease | $224K | Ictero Medical, Inc. |
2 patents as inventor
- US 12070257Ictero Medical, Inc.Aug 27, 2024
- US Ictero Medical, Inc.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#613
Awards as PI#927
Patents#284
Companies
- Ictero Medical, Inc.Leads (SEC Form D) · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.